Recruiting Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment NCT05363280 Conditions Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +25 more Locations University of Alabama at Birmingham — Birmingham, Alabama, United States Cleveland Clinic Florida — Weston, Florida, United States Northwestern University — Chicago, Illinois, United States Siteman Cancer Center, Washington University — St Louis, Missouri, United States View more locations Show fewer locations Loading locations... View Trial Details
Recruiting A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression NCT06682793 Conditions Adenocarcinoma, Breast Diseases, Breast Neoplasms, +57 more Locations Banner MD Anderson Cancer Center — Gilbert, Arizona, United States UCSD Moores Cancer Center — La Jolla, California, United States UCLA Medical Center — Los Angeles, California, United States Mayo Clinic — Jacksonville, Florida, United States View more locations Show fewer locations Loading locations... View Trial Details
Completed ZD6474(Vandetanib) + Alimta Combo Study NCT00506051 Conditions Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more Locations Not specified View Trial Details
Completed Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies NCT01041235 Conditions Adnexal Diseases, Breast Cancer, Breast Diseases, +28 more Locations Mary Crowley Cancer Research Centers (MCCRC) — Dallas, Texas, United States Cancer Therapy and Research Center (CTRC) — San Antonio, Texas, United States View Trial Details
